FRE — Firebrick Pharma Share News
0.000.00%
Last trade - 00:00- AU$8.56m
- AU$7.23m
- AU$0.11m
Brief: Firebrick Pharma Says It Got Written Advice From TGA Of Their Decision
Brief: Firebrick Pharma Ltd Seeks Trading Halt-Fre.Ax
Australia's Firebrick Pharma hits over 1-week high on Malaysia patent grant
Australia Stock Exchange release from FIREBRICK PHARMA : Investor Presentation - Euroz Hartleys Rottnest Conference
Australia Stock Exchange release from FIREBRICK PHARMA : Investor Presentation - Euroz Hartleys Rottnest Conference
Brief: Firebrick Pharma To File Appeal Seeking Immediate Approval Of Nasodine
Australia Stock Exchange release from FIREBRICK PHARMA : FRE to file appeal seeking immediate approval of Nasodine
Australia's Firebrick Pharma jumps on U.S. patent for COVID nasal spray
Australia Stock Exchange release from FIREBRICK PHARMA : Nasodine US Patent Granted for COVID-19
Australia Stock Exchange release from FIREBRICK PHARMA : PRE_NR Ends: 16:42:58
Australia Stock Exchange release from FIREBRICK PHARMA : 31 December Interim Financial Report & Appendix 4D
Australia Stock Exchange release from FIREBRICK PHARMA : Nasodine in vitro and pilot human COVID-19 studies published
Brief: Firebrick Pharma Ltd Says Nasodine Covid-19 Trial Receives Sahpra Approval
Australia Stock Exchange release from FIREBRICK PHARMA : Nasodine COVID-19 trial receives SAHPRA approval